Please use this identifier to cite or link to this item:
|Title:||Gold nanorods as dual photo-sensitizing and imaging agents for two-photon photodynamic therapy||Authors:||Zhao, T.
|Issue Date:||2012||Citation:||Zhao, T., Shen, X., Li, L., Guan, Z., Gao, N., Yuan, P., Yao, S.Q., Xu, Q.-H., Xu, G.Q. (2012). Gold nanorods as dual photo-sensitizing and imaging agents for two-photon photodynamic therapy. Nanoscale 4 (24) : 7712-7719. ScholarBank@NUS Repository. https://doi.org/10.1039/c2nr32196c||Abstract:||Gold nanorods with three different aspect ratios were prepared and their dual capabilities for two-photon imaging and two-photon photodynamic therapy have been demonstrated. These gold nanorods exhibit large two-photon absorption action cross-sections, about two orders of magnitude larger than small organic molecules, which makes them suitable for two-photon imaging. They can also effectively generate singlet oxygen under two-photon excitation, significantly higher than traditional photosensitizers such as Rose Bengal and Indocyanine Green. Such high singlet oxygen generation capability under two-photon excitation was ascribed to their large two-photon absorption cross-sections. Polyvinylpyrrolidone (PVP) coated gold nanorods displayed excellent biocompatibility and high cellular uptake efficiency. The two-photon photodynamic therapy effect and two-photon fluorescence imaging properties of PVP coated gold nanorods have been successfully demonstrated on HeLa cells in vitro using fluorescence microscopy and indirect XTT assay method. These gold nanorods thus hold great promise for imaging guided two-photon photodynamic therapy for the treatment of various malignant tumors. This journal is © 2012 The Royal Society of Chemistry.||Source Title:||Nanoscale||URI:||http://scholarbank.nus.edu.sg/handle/10635/76252||ISSN:||20403364||DOI:||10.1039/c2nr32196c|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.